ASTH logo

ASTRANA HEALTH INC

ASTHNASDAQ
πŸ† #2096 by market capEarnings Nov 5US Equity
$35.45β–² $0.32 (+0.91%)
πŸŒ™ After hours$35.45β–² 0.00%Regular close Β· extended-hours price shown
πŸ””
Track ASTH
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.9%
7dβ–² 1.0%
14dβ–Ό 7.5%
30dβ–Ό 6.6%
ytdβ–² 42.9%
1yβ–² 22.4%
🏦Market Cap
$1.76B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+58.9%
High Growth
πŸ“ŠGross Margin
10.5%
Thin
πŸ’΅FCF Margin
2.6%
Thin
βš–οΈP/S Ratio
0.4x
Cheap
Otter Score
80
Good

Trading Snapshot

Day Range
$35.33 – $36.08
52-Week Range
$18.08 – $51.60
Volume
$2.45B
Avg Volume
$1.94B
Shares Outstanding
49.6M
Next Earnings
Dec 5, 2026

Fundamentals Snapshot

Annual Revenue
$3.18B
Last Q Revenue
$973M
P/E Ratio
42.6
P/S Ratio
0.4x
EPS (TTM)
$0.82
Dividend Yield
0.11%
Dilution (1yr)
+3.3%

Why Investors Own ASTH

  • βœ“High-growth profile β€” revenue up +18.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 76% gross margin and 20% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ASTH logo

ASTRANA HEALTH INC

ASTH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3.2Bβ–² +56.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
9.3%β–Ό βˆ’30.3% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$79Mβ–Ό βˆ’12.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$104Mβ–² +136.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
49.5Mβ–² +3.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$649Mβ–Ό βˆ’$465M YoY
StockOtter Β· stockotter.space

About ASTRANA HEALTH INC

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverageβ€”such as private plans, Medicare, Medicaid, and HMOsβ€”but also extends care to uninsured individuals.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
80/100

Analyst Price Target

β“˜
Average Target
$38.20
β–² +7.8% Upside
High Target$42.15
Low Target$29.80
Based on 30 analysts

Latest News & Updates

GlobeNewsWireΒ·6h ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - ASTH

NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (β€œAstrana” or the β€œCompany”) (NASDAQ: ASTH). Such investors are advised to contact Daniell

Business WireΒ·1d ago

ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $ASTH--ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law.

Business WireΒ·4d ago

PRIVACY ALERT: AWKO Law Investigating Astrana Health Data Breach

SAN FRANCISCO--(BUSINESS WIRE)--AWKO Law LLP is investigating a data breach that led to unauthorized access to the sensitive information of individuals affiliated with Astrana Health, Inc.'s subsidiary, Astrana Health Ma

PRNewsWireΒ·5d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. ("Astrana" or the "Company") (NASDAQ: ASTH).

GlobeNewsWireΒ·7d ago

Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C.

Seeking AlphaΒ·Aug 12

Astrana Health: 81% Full-Risk And Profitable

Astrana Health is rated a buy, trading at a 46% discount to peers despite sector-wide reserve releases clarifying earnings quality concerns. ASTH's Care Enablement platform drove G&A costs from 7.75% to 5.57% of revenue,